{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:00Z","timestamp":1793276940474,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/22\/M\/NZ5\/00668"],"award-info":[{"award-number":["2016\/22\/M\/NZ5\/00668"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-associated macrophages (TAMs) of classic Hodgkin Lymphoma (cHL) contribute to the development of immunosuppressive tumor microenvironment (TME) and are associated with worse treatment outcomes. However, detailed features, functions and therapeutic vulnerabilities of cHL TAMs remain largely unknown. To address this, we analyzed cHL diagnostic biopsies by Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq) and assessed transcriptional, proteomic and metabolic profiles of in vitro TAM models. We show that Reed\u2013Sternberg (RS) cells induce a disease-specific TAM phenotype, characterized by elevated expression of factors involved in chemotaxis, angiogenesis, extracellular matrix remodeling and tumor immune escape. RS cell-conditioned TAMs expressed TGF\u03b2, CCL17 and tryptophan catabolizing enzymes, IDO1 and IL4I1, promoting regulatory T cell recruitment and activation. In addition, we identified the expression of PIM1\/2\/3 kinases in cHL TAMs and characterized PIMs as critical hubs orchestrating RS-macrophage interactions. Pharmacological PIM blockade attenuated the RS-induced TAM transcriptional program. In established TAMs, PIM inhibition or PROTAC-mediated degradation decreased the expression of multiple factors associated with pro-tumoral TAM functions, including IL8, MMP9, CHI3L1\/2, CD206, CD209, PD-L1, CCL17, TGF\u03b2, IL4I1 and IDO1. PIM blockade attenuated TAM-dependent eosinophil chemoattraction, extracellular matrix remodeling, angiogenesis and regulatory T-cell development. Taken together, our study highlights the role of PIMs in the regulation of pathogenic TAM functions in cHL, further supporting the rationale of PIM targeting in this disease.<\/jats:p>","DOI":"10.1038\/s41419-025-08402-5","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T06:44:10Z","timestamp":1766731450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Maciej","family":"Szyd\u0142owski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Garbicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Maroszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ochocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Tabaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Prochorec-Sobieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2920-2672","authenticated-orcid":false,"given":"Patryk","family":"G\u00f3rniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Szyma\u0144ska-Giemza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Ko\u0142kowska-Le\u015bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Kukwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Paszkiewicz-Kozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Toto\u0144-\u017bura\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Radomska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Pilch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2748-9523","authenticated-orcid":false,"given":"Dominika","family":"Nowis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-5100","authenticated-orcid":false,"given":"Jakub","family":"Golab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6134-7425","authenticated-orcid":false,"given":"Micha\u0142","family":"Kurlapski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maciej","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Braczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kaszkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Wo\u0142kow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wiktorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brognard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Licho\u0142ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Lech-Mara\u0144da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7215-0444","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Juszczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"8402_CR1","doi-asserted-by":"publisher","first-page":"13134","DOI":"10.1073\/pnas.0706017104","volume":"104","author":"P Juszczynski","year":"2007","unstructured":"Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, Abramson J, et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA. 2007;104:13134\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8402_CR2","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","volume":"116","author":"MR Green","year":"2010","unstructured":"Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O\u2019Donnell E, et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood. 2010;116:3268\u201377.","journal-title":"Blood"},{"key":"8402_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","volume":"372","author":"SM Ansell","year":"2015","unstructured":"Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma. N Engl J Med. 2015;372:311\u20139.","journal-title":"N Engl J Med"},{"key":"8402_CR4","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","volume":"35","author":"R Chen","year":"2017","unstructured":"Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, et al. Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma. J Clin Oncol. 2017;35:2125\u201332.","journal-title":"J Clin Oncol"},{"key":"8402_CR5","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1182\/bloodadvances.2023010334","volume":"7","author":"SM Ansell","year":"2023","unstructured":"Ansell SM, Br\u00f6ckelmann PJ, von Keudell G, Lee HJ, Santoro A, Zinzani PL, et al. Nivolumab for relapsed\/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study. Blood Adv. 2023;7:6266\u201374.","journal-title":"Blood Adv"},{"key":"8402_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","volume":"4","author":"MGM Roemer","year":"2016","unstructured":"Roemer MGM, Advani RH, Redd RA, Pinkus GS, Natkunam Y, Ligon AH, et al. Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status. Cancer Immunol Res. 2016;4:910\u20136.","journal-title":"Cancer Immunol Res"},{"key":"8402_CR7","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, et al. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019;3:4065\u201380.","journal-title":"Blood Adv"},{"key":"8402_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","volume":"36","author":"MGM Roemer","year":"2018","unstructured":"Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, et al. Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma. J Clin Oncol. 2018;36:942\u201350.","journal-title":"J Clin Oncol"},{"key":"8402_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6:75.","journal-title":"Signal Transduct Target Ther"},{"key":"8402_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med. 2010;362:875\u201385.","journal-title":"N Engl J Med"},{"key":"8402_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1102-3","volume":"18","author":"X Li","year":"2019","unstructured":"Li X, Liu R, Su X, Pan Y, Han X, Shao C, et al. Harnessing tumor-associated macrophages as aids for cancer immunotherapy. Mol Cancer. 2019;18:177.","journal-title":"Mol Cancer"},{"key":"8402_CR12","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","volume":"130","author":"CD Carey","year":"2017","unstructured":"Carey CD, Gusenleitner D, Lipschitz M, Roemer MGM, Stack EC, Gjini E, et al. Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood. 2017;130:2420\u201330.","journal-title":"Blood"},{"key":"8402_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki T, Chong LC, Takata K, Milne K, Hav M, Colombo A, et al. Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. Cancer Discov. 2020;10:406\u201321.","journal-title":"Cancer Discov"},{"key":"8402_CR14","first-page":"2343","volume":"141","author":"BJ Stewart","year":"2023","unstructured":"Stewart BJ, Fergie M, Young MD, Jones C, Sachdeva A, Blain A, et al. Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma. Blood. 2023;141:2343\u201358.","journal-title":"Blood"},{"key":"8402_CR15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood-2019-122535","volume":"134","author":"SS Patel","year":"2019","unstructured":"Patel SS, Weirather JL, Lipschitz M, Lako A, Chen PH, Griffin GK, et al. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative. Blood. 2019;134:2059\u201369.","journal-title":"Blood"},{"key":"8402_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/1878-0261.12616","volume":"14","author":"A Arlt","year":"2020","unstructured":"Arlt A, von Bonin F, Rehberg T, Perez-Rubio P, Engelmann JC, Limm K, et al. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination. Mol Oncol. 2020;14:571\u201389.","journal-title":"Mol Oncol"},{"key":"8402_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19:402\u201321.","journal-title":"Nat Rev Clin Oncol"},{"key":"8402_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1182\/blood-2017-01-760702","volume":"130","author":"M Szydlowski","year":"2017","unstructured":"Szydlowski M, Prochorec-Sobieszek M, Szumera-Cieckiewicz A, Derezinska E, Hoser G, Wasilewska D, et al. Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma. Blood. 2017;130:1418\u201329.","journal-title":"Blood"},{"key":"8402_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14:865\u20138.","journal-title":"Nat Methods"},{"key":"8402_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh3768","volume":"6","author":"HW King","year":"2021","unstructured":"King HW, Wells KL, Shipony Z, Kathiria AS, Wagar LE, Lareau C, et al. Integrated single-cell transcriptomics and epigenomics reveals strong germinal center-associated etiology of autoimmune risk loci. Sci Immunol. 2021;6:eabh3768.","journal-title":"Sci Immunol"},{"key":"8402_CR21","doi-asserted-by":"publisher","first-page":"e0208602","DOI":"10.1371\/journal.pone.0208602","volume":"13","author":"KY Gerrick","year":"2018","unstructured":"Gerrick KY, Gerrick ER, Gupta A, Wheelan SJ, Yegnasubramanian S, Jaffee EM. Transcriptional profiling identifies novel regulators of macrophage polarization. PLoS One. 2018;13:e0208602.","journal-title":"PLoS One"},{"key":"8402_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54512-7","volume":"15","author":"J Paczkowska","year":"2024","unstructured":"Paczkowska J, Tang M, Wright KT, Song L, Luu K, Shanmugam V, et al. Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma. Nat Commun. 2024;15:10740.","journal-title":"Nat Commun"},{"key":"8402_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1172\/JCI31422","volume":"117","author":"A Sica","year":"2007","unstructured":"Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007;117:1155\u201366.","journal-title":"J Clin Invest"},{"key":"8402_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/cells9040938","volume":"9","author":"YH Lin","year":"2020","unstructured":"Lin YH, Wang YH, Peng YJ, Liu FC, Lin GJ, Huang SH, et al. Interleukin 26 skews macrophage polarization towards M1 phenotype by activating cJUN and the NF-\u03baB pathway. Cells. 2020;9:938.","journal-title":"Cells"},{"key":"8402_CR25","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.1073\/pnas.1519644112","volume":"112","author":"B Luan","year":"2015","unstructured":"Luan B, Yoon YS, Le Lay J, Kaestner KH, Hedrick S, Montminy M. CREB pathway links PGE2 signaling with macrophage polarization. Proc Natl Acad Sci USA. 2015;112:15642\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8402_CR26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1021\/acscentsci.7b00261","volume":"3","author":"L Zeng","year":"2017","unstructured":"Zeng L, Wang WH, Arrington J, Shao G, Geahlen RL, Hu CD, et al. Identification of upstream kinases by fluorescence complementation mass spectrometry. ACS Cent Sci. 2017;3:1078\u201385.","journal-title":"ACS Cent Sci"},{"key":"8402_CR27","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/1535-7163.MCT-10-0321","volume":"9","author":"M Chang","year":"2010","unstructured":"Chang M, Kanwar N, Feng E, Siu A, Liu X, Ma D, et al. PIM kinase inhibitors downregulate STAT3(Tyr705) phosphorylation. Mol Cancer Ther. 2010;9:2478\u201387.","journal-title":"Mol Cancer Ther"},{"key":"8402_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1158\/2326-6066.CIR-20-0433","volume":"9","author":"G Xin","year":"2021","unstructured":"Xin G, Chen Y, Topchyan P, Kasmani MY, Burns R, Volberding PJ, et al. Targeting PIM1-mediated metabolism in myeloid suppressor cells to treat cancer. Cancer Immunol Res. 2021;9:454\u201369.","journal-title":"Cancer Immunol Res"},{"key":"8402_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.chembiol.2023.10.023","volume":"31","author":"P Torres-Ayuso","year":"2024","unstructured":"Torres-Ayuso P, Katerji M, Mehlich D, Lookingbill SA, Sabbasani VR, Liou H, et al. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell Chem Biol. 2024;31:326\u2013.e11.","journal-title":"Cell Chem Biol"},{"key":"8402_CR30","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875\u201386.","journal-title":"J Exp Med"},{"key":"8402_CR31","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.4049\/jimmunol.181.8.5396","volume":"181","author":"W Chen","year":"2008","unstructured":"Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol. 2008;181:5396\u2013404.","journal-title":"J Immunol"},{"key":"8402_CR32","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/eji.201445000","volume":"45","author":"C Cousin","year":"2015","unstructured":"Cousin C, Aubatin A, Le Gouvello S, Apetoh L, Castellano F, Molinier-Frenkel V. The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation. Eur J Immunol. 2015;45:1772\u201382.","journal-title":"Eur J Immunol"},{"key":"8402_CR33","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","volume":"170","author":"A Li","year":"2003","unstructured":"Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003;170:3369\u201376.","journal-title":"J Immunol"},{"key":"8402_CR34","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"S Quintero-Fabi\u00e1n","year":"2019","unstructured":"Quintero-Fabi\u00e1n S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Arg\u00e1ez V, Lara-Riegos J, et al. Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. 2019;9:1370.","journal-title":"Front Oncol"},{"key":"8402_CR35","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/onc.2009.292","volume":"28","author":"R Shao","year":"2009","unstructured":"Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009;28:4456\u201368.","journal-title":"Oncogene"},{"key":"8402_CR36","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.3389\/fimmu.2019.02930","volume":"10","author":"J Kzhyshkowska","year":"2019","unstructured":"Kzhyshkowska J, Larionova I, Liu T. YKL-39 as a potential new target for anti-angiogenic therapy in cancer. Front Immunol. 2019;10:2930.","journal-title":"Front Immunol"},{"key":"8402_CR37","first-page":"L117","volume":"268","author":"RA Erger","year":"1995","unstructured":"Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol. 1995;268:L117\u201322.","journal-title":"Am J Physiol"},{"key":"8402_CR38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1165\/rcmb.2012-0499OC","volume":"48","author":"P Akuthota","year":"2013","unstructured":"Akuthota P, Ueki S, Estanislau J, Weller PF. Human eosinophils express functional CCR7. Am J Respir Cell Mol Biol. 2013;48:758\u201364.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"8402_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/01902140802220625","volume":"34","author":"C Ben-Yehuda","year":"2008","unstructured":"Ben-Yehuda C, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N. Airway eosinophil accumulation and eotaxin-2\/CCL24 expression following allergen challenge in BALB\/c mice. Exp Lung Res. 2008;34:467\u201379.","journal-title":"Exp Lung Res"},{"key":"8402_CR40","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.4049\/jimmunol.165.6.2943","volume":"165","author":"J Pan","year":"2000","unstructured":"Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol. 2000;165:2943\u20139.","journal-title":"J Immunol"},{"key":"8402_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06316-9","volume":"9","author":"S Yi","year":"2018","unstructured":"Yi S, Zhai J, Niu R, Zhu G, Wang M, Liu J, et al. Eosinophil recruitment is dynamically regulated by interplay among lung dendritic cell subsets after allergen challenge. Nat Commun. 2018;9:3879.","journal-title":"Nat Commun"},{"key":"8402_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","volume":"132","author":"FZ Cader","year":"2018","unstructured":"Cader FZ, Schackmann RCJ, Hu X, Wienand K, Redd R, Chapuy B, et al. Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment. Blood. 2018;132:825\u201336.","journal-title":"Blood"},{"key":"8402_CR43","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman DJ, Akkari L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell. 2023;186:1627\u201351.","journal-title":"Cell"},{"key":"8402_CR44","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.4049\/jimmunol.181.9.5829","volume":"181","author":"DA Hume","year":"2008","unstructured":"Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol. 2008;181:5829\u201335.","journal-title":"J Immunol"},{"key":"8402_CR45","doi-asserted-by":"publisher","first-page":"e1278331","DOI":"10.1080\/2162402X.2016.1278331","volume":"6","author":"L Bod","year":"2017","unstructured":"Bod L, Lengagne R, Wrobel L, Ramspott JP, Kato M, Avril MF, et al. IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma. Oncoimmunology. 2017;6:e1278331.","journal-title":"Oncoimmunology"},{"key":"8402_CR46","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/1078-0432.CCR-18-0706","volume":"25","author":"S Chatterjee","year":"2019","unstructured":"Chatterjee S, Chakraborty P, Daenthanasanmak A, Iamsawat S, Andrejeva G, Luevano LA, et al. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019;25:1036\u201349.","journal-title":"Clin Cancer Res"},{"key":"8402_CR47","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1158\/0008-5472.CAN-19-2254","volume":"80","author":"B Hu","year":"2020","unstructured":"Hu B, Wang Z, Zeng H, Qi Y, Chen Y, Wang T, et al. Blockade of DC-SIGN+ tumor-associated macrophages reactivates antitumor immunity and improves immunotherapy in muscle-invasive bladder cancer. Cancer Res. 2020;80:1707\u201319.","journal-title":"Cancer Res"},{"key":"8402_CR48","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2015.05.009","volume":"42","author":"P Conde","year":"2015","unstructured":"Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) macrophages control the induction of transplantation tolerance. Immunity. 2015;42:1143\u201358.","journal-title":"Immunity"},{"key":"8402_CR49","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"A Sadik","year":"2020","unstructured":"Sadik A, Somarribas Patterson LF, \u00d6zt\u00fcrk S, Mohapatra SR, Panitz V, Secker PF, et al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression. Cell. 2020;182:1252\u2013.e34.","journal-title":"Cell"},{"key":"8402_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cas.13432","volume":"109","author":"A Masaki","year":"2018","unstructured":"Masaki A, Ishida T, Maeda Y, Ito A, Suzuki S, Narita T, et al. Clinical significance of tryptophan catabolism in Hodgkin lymphoma. Cancer Sci. 2018;109:74\u201383.","journal-title":"Cancer Sci"},{"key":"8402_CR51","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/leu.2008.380","volume":"23","author":"A Carbonnelle-Puscian","year":"2009","unstructured":"Carbonnelle-Puscian A, Copie-Bergman C, Baia M, Martin-Garcia N, Allory Y, Haioun C, et al. The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages. Leukemia. 2009;23:952\u201360.","journal-title":"Leukemia"},{"key":"8402_CR52","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","volume":"5","author":"F Wein","year":"2017","unstructured":"Wein F, Weniger MA, H\u00f6ing B, Arnolds J, H\u00fcttmann A, Hansmann ML, et al. Complex immune evasion strategies in classical Hodgkin lymphoma. Cancer Immunol Res. 2017;5:1122\u201332.","journal-title":"Cancer Immunol Res"},{"key":"8402_CR53","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood.V95.4.1207.004k34_1207_1213","volume":"95","author":"R von Wasielewski","year":"2000","unstructured":"von Wasielewski R, Seth S, Franklin J, Fischer R, H\u00fcbner K, Hansmann ML, et al. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin\u2019s disease, allowing for known prognostic factors. Blood. 2000;95:1207\u201313.","journal-title":"Blood"},{"key":"8402_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/annonc\/8.suppl_2.S89","volume":"8","author":"A Pinto","year":"1997","unstructured":"Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Perin V, et al. The role of eosinophils in the pathobiology of Hodgkin\u2019s disease. Ann Oncol. 1997;8:89\u201396.","journal-title":"Ann Oncol"},{"key":"8402_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70235","volume":"28","author":"S Zicari","year":"2024","unstructured":"Zicari S, Merlino G, Paoli A, Fiascarelli A, Tunici P, Bisignano D, et al. The dual PIM\/FLT3 inhibitor MEN1703 combines synergistically with gilteritinib in FLT3-ITD-mutant acute myeloid leukaemia. J Cell Mol Med. 2024;28:e70235.","journal-title":"J Cell Mol Med"},{"key":"8402_CR56","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1158\/1078-0432.CCR-17-1283","volume":"23","author":"Y Yin","year":"2017","unstructured":"Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23:7375\u201387.","journal-title":"Clin Cancer Res"},{"key":"8402_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06487-y","volume":"15","author":"R Tatsuno","year":"2024","unstructured":"Tatsuno R, Ichikawa J, Komohara Y, Pan C, Kawasaki T, Enomoto A, et al. Pivotal role of IL-8 derived from the interaction between osteosarcoma and tumor-associated macrophages in osteosarcoma growth and metastasis via the FAK pathway. Cell Death Dis. 2024;15:108.","journal-title":"Cell Death Dis"},{"key":"8402_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104119","volume":"353","author":"LQ Fu","year":"2020","unstructured":"Fu LQ, Du WL, Cai MH, Yao JY, Zhao YY, Mou XZ. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020;353:104119.","journal-title":"Cell Immunol"},{"key":"8402_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1158\/2326-6066.CIR-24-0591","volume":"13","author":"AN Clements","year":"2025","unstructured":"Clements AN, Casillas AL, Flores CE, Liou H, Toth RK, Chauhan SS, et al. Inhibition of PIM kinase in tumor-associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy. Cancer Immunol Res. 2025;13:633\u201345.","journal-title":"Cancer Immunol Res"},{"key":"8402_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/bjc.2017.434","volume":"118","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Barbie DA, Flaherty KT. Mechanisms of resistance to immune checkpoint inhibitors. Br J Cancer. 2018;118:9\u201316.","journal-title":"Br J Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08402-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:02:33Z","timestamp":1769536953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08402-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8402"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08402-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PJ: consultancy for Ryvu Therapeutics, received research funding from Menarini Richerche.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Institutional review board approval was obtained for the collection and analysis of tissue samples from patients (Decision number 22\/2019). Animal studies were performed according to the protocol approved by the local bioethical committee and were performed in accordance with the guidelines approved by the 2nd Local Ethics Committee in Warsaw and in accordance with the requirements of the EU (Directive 2010\/63\/EU) and Polish (Dz. U. poz. 266\/15.01.2015) legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided informed consent for participation and utilization of biopsy specimens in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"136"}}